Zhang H - Search Results

1

Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec-7.

Fan T, Liao Q, Zhao Y, Dai H, Song S, He T, Wang Z, Huang J, Zeng Z, Guo H, Zhang H, Qiu X. Fan T, et al. Among authors: zhang h. Cancer Sci. 2023 Feb;114(2):370-383. doi: 10.1111/cas.15631. Epub 2022 Nov 20. Cancer Sci. 2023. PMID: 36310398 Free PMC article.

2

Single-cell profiling of the copy-number heterogeneity in colorectal cancer.

Song S, Feng L, Xi K, Sun Z, Kong D, Luo Z, Pei W, Zhang H. Song S, et al. Among authors: zhang h. Chin Med J (Engl). 2023 Mar 20;136(6):707-718. doi: 10.1097/CM9.0000000000002469. Chin Med J (Engl). 2023. PMID: 36914941 Free PMC article.

3

The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.

Cui J, Zhang L, Yang L, Zhu YL, Fang H, Chen B, Ning Y, Zhang HZ. Cui J, et al. Among authors: zhang l, zhang hz. Cancer Med. 2020 Dec;9(24):9373-9384. doi: 10.1002/cam4.3553. Epub 2020 Oct 20. Cancer Med. 2020. PMID: 33079470 Free PMC article.

4

Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey.

Shi JF, Wang L, Ran JC, Wang H, Liu CC, Zhang HZ, Yang L, Shi SS, Jiang LM, Fan JH, Zhang YM, Wang WH, Ren JS, Zhu L, Zheng ZX, Sun YK, Zou SM, Jiang J, Chen B, Chen HD, Liu GX, Yang L, Huang YC, Guo LW, Wang DB, Zhang YZ, Mao AY, Wang JL, Gong JY, Wei DH, Qiu WQ, Song BB, Zhang K, Li N, Feletto E, Lew JB, Qiao YL, Chen WQ, Dai M, He J. Shi JF, et al. Among authors: zhang ym, zhang hz, zhang k, zhang yz. Cancer. 2021 Jun 1;127(11):1880-1893. doi: 10.1002/cncr.33445. Epub 2021 Mar 30. Cancer. 2021. PMID: 33784413 Free article.

5

TRIB3 reduces CD8⁺ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer.

Shang S, Yang YW, Chen F, Yu L, Shen SH, Li K, Cui B, Lv XX, Zhang C, Yang C, Liu J, Yu JJ, Zhang XW, Li PP, Zhu ST, Zhang HZ, Hua F. Shang S, et al. Sci Transl Med. 2022 Jan 5;14(626):eabf0992. doi: 10.1126/scitranslmed.abf0992. Epub 2022 Jan 5. Sci Transl Med. 2022. PMID: 34985967

6

Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells.

Lv J, Zhou Y, Zhou N, Wang Z, Chen J, Chen H, Wang D, Zhou L, Wei K, Zhang H, Tang K, Ma J, Liu Y, Wan Y, Zhang Y, Zhang H, Huang B. Lv J, et al. Among authors: zhang h, zhang y. Sci Transl Med. 2023 Feb;15(681):eabq6024. doi: 10.1126/scitranslmed.abq6024. Epub 2023 Feb 1. Sci Transl Med. 2023. PMID: 36724242

7

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study.

Liu X, Ou K, Ma X, Gao L, Wang Q, Zhang H, Yang L. Liu X, et al. Among authors: zhang h. BMC Cancer. 2022 Jul 21;22(1):807. doi: 10.1186/s12885-022-09889-3. BMC Cancer. 2022. PMID: 35864467 Free PMC article.

8

ID1 expressing macrophages support cancer cell stemness and limit CD8⁺ T cell infiltration in colorectal cancer.

Shang S, Yang C, Chen F, Xiang RS, Zhang H, Dai SY, Liu J, Lv XX, Zhang C, Liu XT, Zhang Q, Lu SB, Song JW, Yu JJ, Zhou JC, Zhang XW, Cui B, Li PP, Zhu ST, Zhang HZ, Hua F. Shang S, et al. Among authors: zhang c, zhang q, zhang xw, zhang hz, zhang h. Nat Commun. 2023 Nov 23;14(1):7661. doi: 10.1038/s41467-023-43548-w. Nat Commun. 2023. PMID: 37996458 Free PMC article.

9

The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial.

Liu WY, Shi JM, Li N, Wang X, Gao YH, Chi Y, Sun YK, Zhao Q, Zhu YJ, Chen HD, Fang H, Lu NN, Qi SN, Chen B, Wang SL, Song YW, Liu YP, Li YX, Liu Z, Zhou HT, Liang JW, Wang XS, Zhang HZ, Tang Y, Jin J. Liu WY, et al. Among authors: zhang hz. Radiat Oncol. 2022 Dec 28;17(1):214. doi: 10.1186/s13014-022-02182-4. Radiat Oncol. 2022. PMID: 36578032 Free PMC article. Clinical Trial.

10

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.

Cui J, Yang L, Guo L, Shao Y, Tan D, Li N, Zhang H. Cui J, et al. Among authors: zhang h. Oncotarget. 2019 Feb 19;10(15):1539. doi: 10.18632/oncotarget.26723. eCollection 2019 Feb 19. Oncotarget. 2019. PMID: 30863500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120,363 results

Search Page